The End of “Close Enough”: What the FDA’s Shift Means for Human Relevance in Europe and the UK
The trajectory toward human-relevant science was already clear. What the FDA has changed is the level of proof required to move forward. The headlines focus on animal testing, but that is not the substantive shift. The expectation now is that any model, however advanced, must demonstrate meaningful relevance to human biology and be usable in […]
